Company / Debt per Share
Apellis Pharmaceuticals, Inc. Debt per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.84
FY2023
5-year range
$0.84 / $0.95
FY2019-FY2023
Trend
-11.7%
vs FY2022
Sector context
#64 of 82
Health Care
What the data says
Apellis Pharmaceuticals, Inc.'s debt per share of $0.84 is lower than 78% of companies in the Health Care sector (FY2023). Improved from $1.95 to $0.84 over the past 6 years.
Based on SEC 10-K filings.
0.84 in FY2023.
Improved from $1.95 to $0.84 over the past 6 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 82This company $0.84 Sector average $151.59
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2023, debt per share decreased 11.7% year-over-year.
- Ranks #64 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.84 | -11.7% |
| FY2022 | $0.95 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $1.95 | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026